Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Moximed

First Patients Treated in a New Randomized Controlled Trial Evaluating the MISHA® Knee System vs. Non-Surgical Treatment for Knee Osteoarthritis
From Moximed
Via Business Wire
Brian Donovan Joins Moximed as Chief Operating Officer
From Moximed
Via Business Wire
Michael Mydra Joins Moximed as Senior Vice President of Reimbursement and Market Access
From Moximed
Via Business Wire
Robert Spomer Joins Moximed as Senior Vice President of Sales
From Moximed
Via Business Wire
Moximed Completes Closing of Series D Financing for $91 Million to Accelerate Commercialization of MISHA® Knee System, an Implantable Shock Absorber for Knee Osteoarthritis
From Moximed
Via Business Wire
Moximed, Inc. Names Christopher Gleason as Chief Executive Officer
From Moximed
Via Business Wire
James Leech Joins Moximed as Chief Financial and Strategy Officer
From Moximed
Via Business Wire
Moximed Announces Appointment of Dave Amerson to Board of Directors
From Moximed
Via Business Wire
Moximed’s MISHA™ Knee System Treats First Commercial Patients in United States
From Moximed
Via Business Wire
Favorable Five-Year Survivorship of Implantable Shock Absorber and Reduction of Arthroplasty Risk in High-Risk Patients Reported in Peer-Reviewed Publications
From Moximed
Via Business Wire
FDA Authorizes Marketing of MISHA™ Knee System for People Suffering from Knee Osteoarthritis
From Moximed
Via Business Wire
Peer-Reviewed Publication Shows Superiority of Moximed’s MISHA™ Knee System
From Moximed
Via Business Wire
Moximed’s MISHA™ Knee System Achieves Superiority of Primary Endpoint in Pivotal Study
From Moximed
Via Business Wire
Moximed to Unveil Data from Pivotal Study of MISHA™ Knee System for First Time at Orthopaedic Summit (OSET) 2022
From Moximed
Via Business Wire
Moximed Raises $40 Million to Advance World’s First Implantable Shock Absorber for Knee Osteoarthritis
From Moximed
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.